-
Markten
-
Aandelen
Sustainable finance2025 Euronext ESG Trends ReportLees meerA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeLees meerInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondsen
-
Obligaties
European Defence BondsGroupe BPCE lists the first bondLees meerFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Gestructureerde producten
-
Derivaten
Where European Government Bonds Meet the FutureFixed Income derivativesLees meerTrade mini bond futures on main European government bonds
-
Commodities
- Overzicht
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Levering en afwikkeling
- Specificaties en regelingen
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLees meerEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Meer
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLees meerJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 04 Dec 2025 13:07 CET |
INIFY LABORATORIES AB | Kommuniké från extra bolagsstämma i Inify Laboratories AB | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 04 Dec 2025 13:07 CET |
INIFY LABORATORIES AB | Bulletin from the extraordinary general meeting of Inify Laboratories AB | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2025 13:30 CET |
INIFY LABORATORIES AB | Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 10:57 CET |
INIFY LABORATORIES AB | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 10:57 CET |
INIFY LABORATORIES AB | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 12 Nov 2025 15:09 CET |
INIFY LABORATORIES AB | Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Nov 2025 15:09 CET |
INIFY LABORATORIES AB | Inify Laboratories - kallelse till extra bolagsstämma 4 december 2025 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 12 Nov 2025 10:50 CET |
INIFY LABORATORIES AB | Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million | 20103010 Biotechnology | Innsideinformasjon |
| 12 Nov 2025 10:50 CET |
INIFY LABORATORIES AB | Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million | 20103010 Biotechnology | Inside information |
| 29 Oct 2025 11:15 CET |
INIFY LABORATORIES AB | Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 29 Oct 2025 11:15 CET |
INIFY LABORATORIES AB | Correction - Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virksomhet i Storbritannia i rute mot lansering tidlig i 2026 | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 29 Oct 2025 11:15 CET |
INIFY LABORATORIES AB | Korrigering - Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026 | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 29 Oct 2025 08:00 CET |
INIFY LABORATORIES AB | Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virksomhet i Storbritannia i rute mot lansering tidlig i 2026 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 29 Oct 2025 08:00 CET |
INIFY LABORATORIES AB | Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Oct 2025 08:00 CET |
INIFY LABORATORIES AB | Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 29 Aug 2025 11:56 CEST |
INIFY LABORATORIES AB | Inify Laboratories - mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 27 Aug 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories: Stabil tillväxt i Sverige och första patientdiagnostiken levererad i Storbritannien | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 27 Aug 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 27 Aug 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories: Sterk vekst i Sverige og første pasientdiagnostikk levert i Storbritannia | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 21 May 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories AB (publ) - kommuniké från årsstämma | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 21 May 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories AB (publ) - summary of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories: Continued strong growth - construction and establishment in the UK | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 30 Apr 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories: Fortsatt sterk vekst - bygging og etablering i Storbritannia | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 30 Apr 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories: Fortsatt stark tillväxt - uppbyggnad och etablering i Storbritannien | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 16 Apr 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories - Årsredovisning 2024 | 20103010 Biotechnology | Årsrapporter og revisjonsberetninger |
| 16 Apr 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories - Annual Report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 16 Apr 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories - notice of Annual General Meeting on May 20, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Apr 2025 08:00 CEST |
INIFY LABORATORIES AB | Inify Laboratories - kallelse till årsstämma den 20 maj 2025 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 26 Feb 2025 08:00 CET |
INIFY LABORATORIES AB | Inify Laboratories: Salgsvekst på 60 prosent i 4. kvartal og svært positiv respons på ekspansjonen i Storbritannia | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 26 Feb 2025 08:00 CET |
INIFY LABORATORIES AB | Inify Laboratories: 60% försäljningstillväxt och mycket positiv respons på expansionen till Storbritannien | 20103010 Biotechnology | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 26 Feb 2025 08:00 CET |
INIFY LABORATORIES AB | Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 14 Feb 2025 14:01 CET |
INIFY LABORATORIES AB | Inify Laboratories - New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 12 Feb 2025 14:45 CET |
INIFY LABORATORIES AB | Inify Laboratories - Resolution to issue new shares in Private Placement and Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Jan 2025 11:57 CET |
INIFY LABORATORIES AB | Inify Laboratories - mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 24 Jan 2025 20:00 CET |
INIFY LABORATORIES AB | Inify Laboratories - mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 23 Jan 2025 20:49 CET |
INIFY LABORATORIES AB | Inify Laboratories - Final results of the Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jan 2025 07:30 CET |
INIFY LABORATORIES AB | Inify Laboratories - Last day of the subscription period in the Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Jan 2025 07:30 CET |
INIFY LABORATORIES AB | Inify Laboratories - Commencement of subscription period for Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Jan 2025 11:31 CET |
INIFY LABORATORIES AB | Inify Laboratories enter into agreement with Swedish region | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Jan 2025 11:31 CET |
INIFY LABORATORIES AB | Inify Laboratories ingår avtal med Region Västmanland | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 07 Jan 2025 17:05 CET |
INIFY LABORATORIES AB | Inify Laboratories - Registration of prospectus and upcoming launch of Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2024 13:30 CET |
INIFY LABORATORIES AB | Inify Laboratories - mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 16 Dec 2024 08:05 CET |
INIFY LABORATORIES AB | Inify Laboratories: Key information regarding potential Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2024 08:00 CET |
INIFY LABORATORIES AB | Inify Laboratories announces successful placement of fully guaranteed private placement | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2024 12:05 CET |
INIFY LABORATORIES AB | Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed subsequent repair issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Dec 2024 12:00 CET |
INIFY LABORATORIES AB | Inify Laboratories AB (publ) - Kommuniké från extra bolagsstämma | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 06 Dec 2024 12:00 CET |
INIFY LABORATORIES AB | Inify Laboratories AB (publ) - Bulletin from the extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Nov 2024 13:18 CET |
INIFY LABORATORIES AB | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 29 Nov 2024 13:18 CET |
INIFY LABORATORIES AB | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Nov 2024 12:00 CET |
INIFY LABORATORIES AB | Inify Laboratories - kallelse till extra bolagsstämma 6 december 2024 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |